FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2772085397> ?p ?o ?g. }

• W2772085397 endingPage "50" @default.
• W2772085397 startingPage "44" @default.
• W2772085397 abstract "Antibody-drug conjugates (ADCs) represent a promising new class of cancer therapeutics. Currently more than 60 ADCs are in clinical development, however, only very few trials focus on gynecologic malignancies. In this review, we summarize the most recent advances in ADC drug development with an emphasis on how this progress relates to patients diagnosed with gynecologic malignancies and breast cancer.The cytotoxic payloads of the majority of the ADCs that are currently in clinical trials for gynecologic malignancies or breast cancer are auristatins (MMAE, MMAF), maytansinoids (DM1, DM4), calicheamicin, pyrrolobenzodiazepines and SN-38. Both cleavable and noncleavable linkers are currently being investigated in clinical trials. A number of novel target antigens are currently being validated in ongoing clinical trials including folate receptor alpha, mesothelin, CA-125, NaPi2b, NOTCH3, protein tyrosine kinase-like 7, ephrin-A4, TROP2, CEACAM5, and LAMP1. For most ADCs currently in clinical development, dose-limiting toxicities appear to be unrelated to the targeted antigen but more tightly associated with the payload. Rational drug design involving optimization of the antibody, the linker and the conjugation chemistry is aimed at improving the therapeutic index of new ADCs.Antibody-drug conjugates can increase the efficacy and decrease the toxicity of their payloads in comparison with traditional cyctotoxic agents. A better and quicker translation of recent scientific advances in the field of ADCs into rational clinical trials for patients diagnosed with ovarian, endometrial or cervical cancer could create real improvements in tumor response, survival and quality of life for our patients." @default.
• W2772085397 created "2017-12-22" @default.
• W2772085397 creator A5062837404 @default.
• W2772085397 creator A5087043062 @default.
• W2772085397 date "2018-02-01" @default.
• W2772085397 modified "2023-10-01" @default.
• W2772085397 title "The target invites a foe: antibody–drug conjugates in gynecologic oncology" @default.
• W2772085397 cites W1486001319 @default.
• W2772085397 cites W1911328979 @default.
• W2772085397 cites W1968917525 @default.
• W2772085397 cites W1974320281 @default.
• W2772085397 cites W1974567048 @default.
• W2772085397 cites W1985566789 @default.
• W2772085397 cites W1995239905 @default.
• W2772085397 cites W2000568282 @default.
• W2772085397 cites W2005564022 @default.
• W2772085397 cites W2009193838 @default.
• W2772085397 cites W2010442254 @default.
• W2772085397 cites W2011118089 @default.
• W2772085397 cites W2049076023 @default.
• W2772085397 cites W2049490668 @default.
• W2772085397 cites W2057680307 @default.
• W2772085397 cites W2081249139 @default.
• W2772085397 cites W2093580676 @default.
• W2772085397 cites W2112245386 @default.
• W2772085397 cites W2137763083 @default.
• W2772085397 cites W2138654358 @default.
• W2772085397 cites W2158320248 @default.
• W2772085397 cites W2158891743 @default.
• W2772085397 cites W2159967578 @default.
• W2772085397 cites W2202939373 @default.
• W2772085397 cites W2235523093 @default.
• W2772085397 cites W2315322079 @default.
• W2772085397 cites W2490760793 @default.
• W2772085397 cites W2513237238 @default.
• W2772085397 cites W2544930253 @default.
• W2772085397 cites W2560005539 @default.
• W2772085397 cites W2567395185 @default.
• W2772085397 cites W2595349270 @default.
• W2772085397 cites W2597045666 @default.
• W2772085397 cites W2603196594 @default.
• W2772085397 cites W379205315 @default.
• W2772085397 cites W4244008531 @default.
• W2772085397 cites W4245511223 @default.
• W2772085397 cites W838749923 @default.
• W2772085397 doi "https://doi.org/10.1097/gco.0000000000000432" @default.
• W2772085397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29227302" @default.
• W2772085397 hasPublicationYear "2018" @default.
• W2772085397 type Work @default.
• W2772085397 sameAs 2772085397 @default.
• W2772085397 citedByCount "14" @default.
• W2772085397 countsByYear W27720853972018 @default.
• W2772085397 countsByYear W27720853972019 @default.
• W2772085397 countsByYear W27720853972020 @default.
• W2772085397 countsByYear W27720853972021 @default.
• W2772085397 countsByYear W27720853972022 @default.
• W2772085397 countsByYear W27720853972023 @default.
• W2772085397 crossrefType "journal-article" @default.
• W2772085397 hasAuthorship W2772085397A5062837404 @default.
• W2772085397 hasAuthorship W2772085397A5087043062 @default.
• W2772085397 hasBestOaLocation W27720853972 @default.
• W2772085397 hasConcept C121608353 @default.
• W2772085397 hasConcept C126322002 @default.
• W2772085397 hasConcept C143998085 @default.
• W2772085397 hasConcept C159654299 @default.
• W2772085397 hasConcept C203014093 @default.
• W2772085397 hasConcept C2777045440 @default.
• W2772085397 hasConcept C2778245361 @default.
• W2772085397 hasConcept C2780035454 @default.
• W2772085397 hasConcept C2780427987 @default.
• W2772085397 hasConcept C2780435969 @default.
• W2772085397 hasConcept C535046627 @default.
• W2772085397 hasConcept C64903051 @default.
• W2772085397 hasConcept C71924100 @default.
• W2772085397 hasConcept C98274493 @default.
• W2772085397 hasConceptScore W2772085397C121608353 @default.
• W2772085397 hasConceptScore W2772085397C126322002 @default.
• W2772085397 hasConceptScore W2772085397C143998085 @default.
• W2772085397 hasConceptScore W2772085397C159654299 @default.
• W2772085397 hasConceptScore W2772085397C203014093 @default.
• W2772085397 hasConceptScore W2772085397C2777045440 @default.
• W2772085397 hasConceptScore W2772085397C2778245361 @default.
• W2772085397 hasConceptScore W2772085397C2780035454 @default.
• W2772085397 hasConceptScore W2772085397C2780427987 @default.
• W2772085397 hasConceptScore W2772085397C2780435969 @default.
• W2772085397 hasConceptScore W2772085397C535046627 @default.
• W2772085397 hasConceptScore W2772085397C64903051 @default.
• W2772085397 hasConceptScore W2772085397C71924100 @default.
• W2772085397 hasConceptScore W2772085397C98274493 @default.
• W2772085397 hasIssue "1" @default.
• W2772085397 hasLocation W27720853971 @default.
• W2772085397 hasLocation W27720853972 @default.
• W2772085397 hasLocation W27720853973 @default.
• W2772085397 hasOpenAccess W2772085397 @default.
• W2772085397 hasPrimaryLocation W27720853971 @default.
• W2772085397 hasRelatedWork W152554689 @default.
• W2772085397 hasRelatedWork W2036093957 @default.
• W2772085397 hasRelatedWork W2279724176 @default.

• next